Item 1.01. Entry into a Material Definitive Agreement.

On January 20, 2021, One World Pharma, Inc. (the "Company") completed the sale of a Promissory Note in the principal amount of $290,000 (the "Note") to AJB Capital Investments LLC (the "Investor") for a purchase price of $281,300, pursuant to a Securities Purchase Agreement between the Company and the Investor (the "Purchase Agreement"). The transaction was effected pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) promulgated thereunder.

The Note matures on October 20, 2021 (the "Maturity Date"), bears interest at a rate of 10% per annum, and, following an event of default only, is convertible into shares of the Company's common stock at a conversion price equal to the lesser of 90% of the lowest trading price during (i) the 20 trading day period preceding the issuance date of the note, or (ii) the 20 trading day period preceding date of conversion of the Note. The Note is also subject to covenants, events of defaults, penalties, default interest and other terms and conditions customary in transactions of this nature.

Pursuant to the Purchase Agreement, the Company will pay a commitment fee to the Investor in the amount of $200,000 (the "Commitment Fee") in the form of 2,000,000 shares of the Company's common stock (the "Commitment Fee Shares"). During the six month period following the six month anniversary of the closing date (the "Adjustment Period"), the Investor shall be entitled to be issued additional shares of common stock of the Company to the extent the Investor's sale of the Commitment Fee Shares has resulted in net proceeds in an amount less than the Commitment Fee. If the Company repays the Note on or prior to the Maturity Date, the Company may redeem 1,000,000 of the Commitment Fee Shares for a nominal redemption price of $1.00.

The obligations of the Company to the Investor under the Note and the Purchase Agreement are secured by a lien on the Company's assets pursuant to a Security Agreement between the Company and the Investor.

The information set forth above is qualified in its entirety by reference to the actual terms of the Note, the Purchase Agreement, and the Security Agreement, which have been filed as Exhibits 4.1, 10.1 and 10.2, respectively, to this Current Report on Form 9-K, and which are incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 1.01 is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Exhibit 4.1      Promissory Note of One World Pharma, Inc. in the principal amount
               of $290,000 issued to AJB Capital Investments LLC, dated January
               20, 2021

Exhibit 10.1     Securities Purchase Agreement, dated as of January 20, 2021,
               between One World Pharma, Inc. and AJB Capital Investments LLC

Exhibit 10.2     Security Agreement, dated as of January 20, 2021, between One
               World Pharma, Inc. and AJB Capital Investments LLC

© Edgar Online, source Glimpses